Copyright
©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Feb 7, 2006; 12(5): 691-696
Published online Feb 7, 2006. doi: 10.3748/wjg.v12.i5.691
Published online Feb 7, 2006. doi: 10.3748/wjg.v12.i5.691
Table 2 Correlation between TP53INP1 expression levels and clinicopathologic features in gastric cancer
TP53INP1-positive(n=91 of 142 patients) | TP53INP1-negative (n=51 of 142 patients) | P value | |
Age (years) | |||
<60 | 31 | 18 | NS |
≥60 | 60 | 33 | |
Sex | |||
Male | 68 | 36 | NS |
Female | 23 | 15 | |
Location | |||
Cardia | 20 | 22 | |
Body | 58 | 26 | 0.0193 |
Antrum | 13 | 3 | |
Histological type | |||
Differentiateda | 62 | 14 | |
Undifferentiatedb | 29 | 37 | <0.0001 |
Tumor invasion | |||
T1a+T1b | 23 | 4 | 0.0111 |
T2+T3+T4 | 68 | 47 | |
Lymph node metastasis | |||
Positive | 5 | 11 | 0.0037 |
Negative | 86 | 40 | |
Liver metastasis | |||
Positive | 0 | 5 | 0.0024 |
Negative | 91 | 46 | |
Lymphatic invasion | |||
Positive | 50 | 42 | 0.0010 |
Negative | 41 | 9 |
- Citation: Jiang PH, Motoo Y, Garcia S, Iovanna JL, Pébusque MJ, Sawabu N. Down-expression of tumor protein p53-induced nuclear protein 1 in human gastric cancer. World J Gastroenterol 2006; 12(5): 691-696
- URL: https://www.wjgnet.com/1007-9327/full/v12/i5/691.htm
- DOI: https://dx.doi.org/10.3748/wjg.v12.i5.691